Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to ...

A secondary analysis of a large trial shows that exposure to the HIV drug abacavir is linked to an elevated risk for major ...

A prominent South African HIV activist is calling on Brazil, China, India and Thailand to step in to help fill the void left ...

This isn’t about managing the AIDS pandemic. It’s about ending it — and letting a new generation grow and thrive free of its ...

Lower-income countries will gain access to a "game-changing" HIV prevention drug with a new deal signed between US ...

Rep. Marjorie Taylor Greene (R-GA) ranted about how the U.S. sends money to Africa to prevent the spread of HIV, arguing that ...

Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...

Several Midwestern Cities have been designated as HIV “hotspots” due to the rising number of new cases; and the South ...

Motsoaledi revealed that Treasury has provided R753 million (R753 528 000) to bolster the department’s HIV/Aids initiatives.

Lower-income countries, including South Africa, gain unprecedented access to lenacapavir, a revolutionary HIV prevention drug ...

Sexual health doesn’t always get the spotlight it deserves. But modern HIV protection platform Mistr PrEP is helping change ...

Gilead Sciences (GILD) stock in focus as the company joins The Global Fund to expand access to lenacapavir, an HIV PrEP ...